Clinical Study No. DRI10734, [......] tolerability of SAR110894D at the doses of 0.5 mg, 2 mg, and 5 mg/day for 24 weeks in patients with mild to moderate Alzheimer's Disease on stable donepezil (2011–2013)
- Grant type:
- Sanofi-Aventis Australia Pty Ltd
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- Sanofi-Aventis Australia Pty Ltd
